miR-30 family also inhibits cell migration, invasiveness, and metastasis in vitro in other tumors, such as lung, breast, and hepatocellular cancer [21], [44]–[46], by targeting SNAI1[21], [44] and Vimentin [45], [46]. The gene discussed is VIM; the disease is hepatocellular carcinoma.